Yogurt in a white bowl next to a wooden spoon with probiotic pills

istock-1345980067-1800x900

Five men smiling with lab materials behind them.

picture1hpy

Since antibiotics tend to have negative side effects on the gut, researchers sought an alternative in an unexpected place: yogurt.

Engineered probiotics kill <em>H. pylori</em>, a cancer-causing bacterium

News

A headshot of Arvinder Dhalla wearing a black blazer.

ranipill

On a black surface sits one clear capsule containing two white and metallic L-SOMA devices and another clear capsule broken open with three L-SOMA devices next to it. 

alex-abramson-headshot

A drawing of a purple hand with 4 pills in the open palm. One pill contains a syringe. In the background are DNA, antibodies, a cross-sectional diagram of a robotic capsule, and mathematic equations. 

62448-article-image-needle-1800x900

A headshot of Alex Abramson hearing a navy blazer, light blue shirt, and navy tie. 

A midsection shot of a scientist holding the RaniPill between their thumb and pointer finger. In the background, their white lab coat is embroidered with the Rani Therapeutics logo. 

Researchers developed ingestible capsules that inject drugs into the stomach and small intestine, providing a novel oral delivery method for biologics.

Robotic pills deliver gastrointestinal injections

Articles

A woman wearing a blue shirt, beige coat, and white purse examines pasta on a supermarket shelf. 

1sn7-assembly-1

A headshot of Franziska Ersoy wearing a blue button-up shirt. 

500x400

A bundle of wheat, a burlap sack full of grain, a pile of grain, and wooden bowl filled with flour sit atop a wooden surface. 

1619303sd-a-leffler-1

A headshot of Dan Leffler wearing a blue gingham shirt and a gray jacket. 

foto-franziskaersoy-farbe

A rainbow protein structure of the kumamolisin-As enzyme. 

1800x900-3

A blue 3D rendering of the human digestive system shows the small intestine in orange and a zoomed-in image of the intestinal villi. 

Researchers develop gluten-degrading enzymes to administer as drugs or incorporate into food and explore therapies that block downstream disease checkpoints.

Taming the immune response to gluten to treat celiac disease

1-0325-cover

March 2025

Surface rendering of two interacting proteins (green and peach) bound together by a small molecule ligand at their interface, illustrating a protein-ligand binding event.

untitled-2

primary-lockup-p-500-1-64e0fe115-1

Salad Technologies

Learn how molecular dynamics, AI-aided design, and structural insights combine to reshape how therapeutic proteins are created, validated, and optimized.

Computational approaches to drug design

Compendium

Stem cells are shown as clear, purple, and blue spheres against a dark blue and black background.

article

Diagram showing how patient-derived somatic cells are reprogrammed into iPSCs using Yamanaka factors and then differentiated into specialized cell types such as neurons, cardiomyocytes, and hepatocytes.

ips-cells-image

BPS Bioscience

Human-relevant, ready-to-use stem cell models are reshaping drug discovery, toxicity testing, and personalized medicine.

Improving translational research with iPSC-derived cells

mike-heaven-phd

Characterizing lipid nanoparticles for RNA therapeutic development

205c4df9-5f8b-4936-b768-3f926ab08bbc

Inotiv

Integrated multiomics and advanced nanoparticle analytics are improving how researchers perform RNA delivery, increasing therapeutic success.

stomach

Engineered probiotics kill H. pylori, a cancer-causing bacterium

Robotic pills deliver gastrointestinal injections

Taming the immune response to gluten to treat celiac disease

Subscribe to our eNewsletters

Sponsored

March 2025